Royal Bank Of Canada Biogen Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Biogen Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 343,194 shares of BIIB stock, worth $54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

343,194

Previous 395,712 13.27%

Holding current value

$54 Million

Previous $91.7 Million 27.48%

% of portfolio

0.01%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $9.93 Million - $12.4 Million	-52,518 Reduced 13.27%	343,194 $66.5 Million
Q2 2024 Nov 06, 2024	SELL	$190.52 - $236.72 $263,108 - $326,910	-1,381 Reduced 0.35%	395,712 $91.7 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $1.48 Million - $1.84 Million	-7,768 Reduced 1.92%	397,093 $92.1 Million
Q1 2024 Nov 05, 2024	BUY	$212.02 - $267.71 $1.31 Million - $1.66 Million	6,185 Added 1.56%	403,278 $87 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $6.54 Million - $8.26 Million	30,847 Added 8.25%	404,861 $87.3 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $15 Million - $18.1 Million	67,460 Added 22.01%	374,014 $96.8 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $11.6 Million - $13.1 Million	-45,986 Reduced 13.04%	306,554 $78.8 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $18.1 Million - $20.9 Million	65,659 Added 22.89%	352,540 $100 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $24.9 Million - $28.3 Million	-96,925 Reduced 25.25%	286,881 $79.8 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $33.2 Million - $40.3 Million	131,377 Added 52.05%	383,806 $106 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $8.43 Million - $11.6 Million	-43,308 Reduced 14.64%	252,429 $67.4 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $6.28 Million - $7.46 Million	33,466 Added 12.76%	295,737 $60.3 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $3.42 Million - $4.31 Million	-17,642 Reduced 6.3%	262,271 $55.2 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $2.49 Million - $3.2 Million	-11,106 Reduced 3.82%	279,913 $67.2 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $27.4 Million - $35.7 Million	-96,849 Reduced 24.97%	291,019 $82.4 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $100 Million - $161 Million	387,868 New	387,868 $134 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Biogen Inc. Transaction History